• Mashup Score: 2

    Since the late 1960s, virtually all newborns in Germany have been standardly tested for a number of rare but severe diseases, since a timely diagnosis and treatment of these diseases significantly improves their prognosis. Thousands of young patients have profited from Germany’s newborn screening program. In part, its success is also due to the program’s continued development, which led to the inclusion of further target diseases and new methods of analysis. The maturation of new genomic technologies now

    Tweet Tweets with this article
    • Our @BMBF_Bund project "NEW_LIVES: Genomic Newborn Screening Programs" now has a website! #gnbs If you'd like to learn more about the opportunities and challenges of using genome sequencing to diagnose and treat rare diseases in newborns👶, please visit: https://t.co/RwuUYzDkXL https://t.co/7yZlb84NWO